chitosan has been researched along with Cardiac Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Luo, X | 1 |
El-Shetry, ES; Hamed Arisha, A; Khater, SI; Metwally, MMM; Mohamed, AA; Mostafa-Hedeab, G | 1 |
Henderson, S; Jiang, P; Lee, JM; Lee, TD; Zhou, J | 1 |
Campana Filho, SP; Dallan, LA; de Oliveira, SA; Gutierrez, PS; Lisboa, LA; Lopes, JB; Moreira, LF; Stolf, NA | 1 |
Vlahakes, GJ | 1 |
Gu, Q; Jiang, L; Zhang, X | 1 |
1 review(s) available for chitosan and Cardiac Diseases
Article | Year |
---|---|
Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
Topics: Antineoplastic Agents; Cardiotoxicity; Cardiovascular Diseases; Chitosan; Heart Diseases; Humans; Neoplasms; Pharmaceutical Preparations | 2023 |
5 other study(ies) available for chitosan and Cardiac Diseases
Article | Year |
---|---|
Chitosan-stabilized selenium nanoparticles alleviate cardio-hepatic damage in type 2 diabetes mellitus model via regulation of caspase, Bax/Bcl-2, and Fas/FasL-pathway.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Blood Glucose; Caspases; Chitosan; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Fas Ligand Protein; fas Receptor; Heart Diseases; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Diseases; Male; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Selenium; Signal Transduction; Streptozocin | 2021 |
Reduction in postsurgical adhesion formation after cardiac surgery by application of N,O-carboxymethyl chitosan.
Topics: Administration, Topical; Animals; Biocompatible Materials; Cardiac Surgical Procedures; Chemistry, Pharmaceutical; Chitosan; Disease Models, Animal; Female; Gels; Heart Diseases; Male; Rabbits; Severity of Illness Index; Swine; Time Factors; Tissue Adhesions | 2010 |
Synergism between keratinocyte growth factor and carboxymethyl chitosan reduces pericardial adhesions.
Topics: Animals; Chitosan; Drug Synergism; Fibroblast Growth Factor 7; Heart Diseases; Male; Pericardium; Swine; Tissue Adhesions | 2010 |
Invited commentary.
Topics: Chitosan; Drug Synergism; Fibroblast Growth Factor 7; Heart Diseases; Pericardium; Tissue Adhesions | 2010 |
[The industrialization of regenerative medicine--a potential market of $ 500 billion].
Topics: Animals; Biocompatible Materials; Cell Differentiation; Cell Proliferation; Chitosan; Diabetes Mellitus; Fibrin; Fibroblast Growth Factors; Heart Diseases; Humans; Hyaluronic Acid; Mice; Regenerative Medicine; Spinal Injuries; Stem Cell Transplantation; Stem Cells; Tissue Engineering | 2007 |